CA-GSMA
17.9.2018 17:02:03 CEST | Business Wire | Press release
The GSMA today reported the highlights of the 2018 Mobile World Congress Americas, which was held September 12-14 at the Los Angeles Convention Center (LACC). Over 55 percent of this year’s nearly 22,000 Mobile World Congress Americas attendees held senior-level positions, including more than 2,500 CEOs. An additional 6,500 students attended the first Youth Mobile Festival (YoMo) held at Mobile World Congress Americas.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180917005473/en/
Under the theme “Imagine a Better Future,” Mobile World Congress Americas illustrated the positive impact of mobile on consumers and businesses across North America and Latin America. Over three days, attendees from 110 countries gathered to debate and discuss the key trends shaping the mobile industry, including nearly 220 media and industry analysts who were on hand to report on the many developments coming out of the event. Approximately five percent of this year’s attendees held roles in the media and entertainment sector, while more than 4,800 attendees, or 22 percent, were female.
“This year’s show builds on the success of last year’s inaugural event, with a higher number of senior-level attendees from the mobile ecosystem, as well as adjacent industries such as media and entertainment,” said John Hoffman, CEO, GSMA Ltd. “Feedback from participating companies indicates that Mobile World Congress Americas delivered on their goals of developing new business, promoting new technologies and products and building visibility amongst industry influencers. We are really pleased with our first event here in LA and look forward to extending this in 2019.”
Industry Leaders Took to the Stage
With nearly 75 hours of program content and over 400 speakers participating in the keynotes and track sessions, 4YFN and Summits, the Mobile World Congress Americas conference program highlighted themes including the Fourth Industrial Revolution, Government and Public Policy, Innovation, Media and Entertainment, and Networks. Keynote sessions featured CEOs and senior executives from a range of leading organizations including AEG, AT&T Mobility & Entertainment, Bharti Enterprises, Boingo Wireless, CTIA, HBO, Idealab, Los Angeles Department of Transportation, Nokia, Pandora, Samsung Electronics North America, Sprint, Verizon Wireless, Vice International, VUBIQUITY and WURL.
Showcasing the Latest in Mobile
Nearly 1,000 participating companies showcased the latest in mobile technology, including Accenture, Amazon, American Express OPEN, ARM, BMW, Cisco, Dell, Ericsson, Gemalto, Google, Hewlett Packard Enterprise, IBM, Infosys, Mastercard, McAfee, NBC Universal, Nokia Solutions, Samsung Networks, Sprint, Synchronoss, Syniverse, T-Mobile USA, TELUS, Verizon Wireless, VMware and Vodafone America, amongst others. The expanded exhibition floor also featured 13 country and regional pavilions, representing Canada, China, Finland, France, India, Ireland, South Korea, Turkey, the United Kingdom and the United States.
The Innovation City returned to the Americas, featuring industry leaders such as BMW, Google and KT Corporation, with a range of exciting demonstrations that highlighted the impact of intelligent connectivity – which combines 5G and the Internet of Things with artificial intelligence and big data – in our everyday lives. The Innovation City also showcased the GSMA’s work supporting the UN Sustainable Development Goals (SDGs).
4YFN Convened Today’s Brightest Innovators
A highlight of Mobile World Congress Americas, the 4YFN Startup Event brought together more than 130 startups, investors, corporations and public institutions to connect and launch new ventures together. Startups attended the event from countries such as Colombia, Honduras, India, Israel, Mexico, South Korea, Spain, the United Kingdom and the United States. 4YFN featured a competition between five startup finalists, with OpenAsApp winning the 2018 4YFN Americas Award.
YoMo Attended by 6,500 Students
The Youth Mobile Festival (YoMo) debuted in the Americas after its success at Mobile World Congress Barcelona, inspiring youth from underserved communities in Southern California to pursue careers in STEAM fields through unique hands-on learning activities. More than 6,500 students participated in the three-day program, which featured interactive learning opportunities and workshops from hundreds of educators and area organizations.
Women4Tech: Closing the Gender Gap
Women4Tech, a program designed to address the persistent gender gap in female representation in the mobile industry, offered attendees the Women4Tech Summit, speed coaching and networking events, and a discussion panel at 4YFN. Women4Tech Summit speakers hailed from companies including Accenture, AT&T, Cisco, the City of Los Angeles, Deloitte, EY, Facebook, Millicom, NBA, NBC Universal, Nokia, Oath, Reuters and the Volvo Tech Fund, amongst others.
Mobile World Congress Americas Confirms LA Commitment
The GSMA confirmed that Mobile World Congress Americas will be held in Los Angeles at the LACC for the next two years. The 2019 Mobile World Congress Americas is scheduled to take place October 22-24, 2019.
“We’re particularly gratified with the response we’ve seen from the LA creative community to our first Mobile World Congress Americas. I would like to thank CTIA for their partnership and contributions to our success this year, and also extend our gratitude to all of our attendees, exhibitors, sponsors, partners, the LACC and the City of Los Angeles for their outstanding support. We look forward to even bigger and better things in LA in 2019,” concluded Hoffman.
For more information on the 2018 Mobile World Congress Americas, please visit www.mwcamericas.com .
-ENDS-
Note to editor : *This figure represents the number individual attendees at the event, including delegates, exhibitors, contractors and media; it does not represent the total number of entries to the event.
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with over 350 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA.
About CTIA
CTIA® (www.ctia.org ) represents the U.S. wireless communications industry and the companies throughout the mobile ecosystem that enable Americans to lead a 21st century connected life. The association’s members include wireless carriers, device manufacturers, suppliers as well as apps and content companies. CTIA vigorously advocates at all levels of government for policies that foster continued wireless innovation and investment. The association also coordinates the industry’s voluntary best practices, hosts educational events that promote the wireless industry and co-produces the industry’s leading wireless tradeshow. CTIA was founded in 1984 and is based in Washington, D.C.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180917005473/en/
Contact:
For the GSMA: Amelise Lane alane@webershandwick.com 212.546.7830 or Ivette López ilopez@gsma.com 678.429.5066 or GSMA Press Office pressoffice@gsma.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
